皮肤性病指南

订阅

MedSci主页 / 所有栏目 / 皮肤性病指南

中药配方颗粒外用治疗皮肤病的专家建议

2021-12-30 中华中医药学会皮肤科专业委员会 中国中西医结合皮肤性病学杂志

皮肤疾病中药配方颗粒外用

中药配方颗粒是由单味中药饮片经水加热提取、分离、浓缩、干燥、制粒而成的颗粒，现已被广大医务人员及患者所接受。

中文标题：

中药配方颗粒外用治疗皮肤病的专家建议

发布机构：

中华中医药学会皮肤科专业委员会

发布日期：

2021-12-30

简要介绍：

中药配方颗粒是由单味中药饮片经水加热提取、分离、浓缩、干燥、制粒而成的颗粒，现已被广大医务人员及患者所接受。为指导医务人员在皮肤病外治中合理、规范地使用中药配方颗粒，保障患者用药安全，中华中医药学会皮肤科分会组织部分专家制定本建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=中药配方颗粒外用治疗皮肤病的专家建议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b60151c0023296f7, title=中药配方颗粒外用治疗皮肤病的专家建议, enTitle=, guiderFrom=中国中西医结合皮肤性病学杂志, authorId=0, author=, summary=中药配方颗粒是由单味中药饮片经水加热提取、分离、浓缩、干燥、制粒而成的颗粒，现已被广大医务人员及患者所接受。, cover=https://img.medsci.cn/2022119/1642597531661_5579292.jpg, journalId=0, articlesId=null, associationId=874, associationName=中华中医药学会皮肤科专业委员会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Dec 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">中药配方颗粒是由单味中药饮片经水加热提取、分离、浓缩、干燥、制粒而成的颗粒，现已被广大医务人员及患者所接受。为指导医务人员在皮肤病外治中合理、规范地使用中药配方颗粒，保障患者用药安全，中华中医药学会皮肤科分会组织部分专家制定本建议。</span></p>, tagList=[TagDto(tagId=27230, tagName=皮肤疾病), TagDto(tagId=121795, tagName=中药配方颗粒外用)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=1, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6157, appHits=165, showAppHits=0, pcHits=1595, showPcHits=5990, likes=0, shares=21, comments=10, approvalStatus=1, publishedTime=Wed Jan 19 21:02:30 CST 2022, publishedTimeString=2021-12-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Jan 19 21:04:40 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 18:00:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中药配方颗粒外用治疗皮肤病的专家建议.pdf)])
中药配方颗粒外用治疗皮肤病的专家建议.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1225206, encodeId=f81f1225206e5, content=打不开？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:38:43 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225209, encodeId=e147122520962, content=收到，谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:52:03 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224899, encodeId=a21c122489913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/34b3ac2653784f07b2421cd401ae9b8d/30dbd5a9312247b49ef5b6110be6e58f.jpg, createdBy=4b095468837, createdName=forensic2009, createdTime=Tue Jun 07 08:43:52 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214782, encodeId=eb631214e82f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213958, encodeId=09fa121395888, content=外用，效果很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38118133455, createdName=ms1000000658335553, createdTime=Sun Apr 24 19:26:43 CST 2022, time=2022-04-24, status=1, ipAttribution=)]
    2022-06-08 ms9000000448509045

    打不开？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1225206, encodeId=f81f1225206e5, content=打不开？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:38:43 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225209, encodeId=e147122520962, content=收到，谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:52:03 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224899, encodeId=a21c122489913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/34b3ac2653784f07b2421cd401ae9b8d/30dbd5a9312247b49ef5b6110be6e58f.jpg, createdBy=4b095468837, createdName=forensic2009, createdTime=Tue Jun 07 08:43:52 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214782, encodeId=eb631214e82f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213958, encodeId=09fa121395888, content=外用，效果很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38118133455, createdName=ms1000000658335553, createdTime=Sun Apr 24 19:26:43 CST 2022, time=2022-04-24, status=1, ipAttribution=)]
    2022-06-08 ms9000000448509045

    收到，谢谢！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1225206, encodeId=f81f1225206e5, content=打不开？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:38:43 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225209, encodeId=e147122520962, content=收到，谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:52:03 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224899, encodeId=a21c122489913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/34b3ac2653784f07b2421cd401ae9b8d/30dbd5a9312247b49ef5b6110be6e58f.jpg, createdBy=4b095468837, createdName=forensic2009, createdTime=Tue Jun 07 08:43:52 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214782, encodeId=eb631214e82f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213958, encodeId=09fa121395888, content=外用，效果很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38118133455, createdName=ms1000000658335553, createdTime=Sun Apr 24 19:26:43 CST 2022, time=2022-04-24, status=1, ipAttribution=)]
    2022-06-07 forensic2009

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1225206, encodeId=f81f1225206e5, content=打不开？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:38:43 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225209, encodeId=e147122520962, content=收到，谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:52:03 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224899, encodeId=a21c122489913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/34b3ac2653784f07b2421cd401ae9b8d/30dbd5a9312247b49ef5b6110be6e58f.jpg, createdBy=4b095468837, createdName=forensic2009, createdTime=Tue Jun 07 08:43:52 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214782, encodeId=eb631214e82f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213958, encodeId=09fa121395888, content=外用，效果很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38118133455, createdName=ms1000000658335553, createdTime=Sun Apr 24 19:26:43 CST 2022, time=2022-04-24, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1225206, encodeId=f81f1225206e5, content=打不开？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:38:43 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225209, encodeId=e147122520962, content=收到，谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=826c6389720, createdName=ms9000000448509045, createdTime=Wed Jun 08 15:52:03 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224899, encodeId=a21c122489913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/34b3ac2653784f07b2421cd401ae9b8d/30dbd5a9312247b49ef5b6110be6e58f.jpg, createdBy=4b095468837, createdName=forensic2009, createdTime=Tue Jun 07 08:43:52 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214782, encodeId=eb631214e82f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213958, encodeId=09fa121395888, content=外用，效果很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38118133455, createdName=ms1000000658335553, createdTime=Sun Apr 24 19:26:43 CST 2022, time=2022-04-24, status=1, ipAttribution=)]
    2022-04-24 ms1000000658335553

    外用，效果很好

    0

相关指南

德国 S3 寻常型银屑病治疗指南，改编自 EuroGuiDerm – 第 2 部分：治疗监测和特定临床或合并症

德国皮肤病学会 (DDG) · 2021-07-21

德国 S3 寻常型银屑病治疗指南，改编自 EuroGuiDerm – 第 1 部分：治疗目标和治疗建议

德国皮肤病学会 (DDG) · 2021-06-17

S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 2 部分：治疗、危险因素和其他专题

德国皮肤病学会 (DDG) · 2021-08-02

2021 S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 1 部分：分类、诊断、预防、活动评分

德国皮肤病学会 (DDG) · 2021-08-13

国际 WAO/EAACI 遗传性血管性水肿管理指南 – 2021 年修订和更新

世界过敏组织(WAO,Word Allerge Organization) · 2022-01-10

2017 JDA临床实践指南：弹力纤维性假黄瘤

日本皮肤病协会(JDA,Japanese Dermatological Association) · 2022-01-12